Jotam G. Pasipanodya

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study”.

Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study

Clinical Infectious Diseases(2022)10.1093/cid/ciac511

N/A

0.652DataRank · unranked

15 citations

Stellah Mpagama, О. Б. Огарков, Mark R. Conaway, Shahriar Ahmed, С. Н. Жданова +20 more

Prevalence and trends of hepatitis B and C virus biomarkers in Zimbabwe: comparative analyses of a nation’s blood-donor surveillance data and meta-analyses of population studies

Infectious Diseases(2024)10.1080/23744235.2024.2351045

N/A

0DataRank · unranked

3 citations

Edmore Munongo, Tonderai Mapako, Lucy Marowa, Alex Gasasira, Jotam G. Pasipanodya +2 more

Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol

BMJ Open(2024)10.1136/bmjopen-2024-088389

N/A

0DataRank · unranked

1 citations

Irene Mbabazi, Ruth Nabisere, Lucy Alinaitwe, Brian Otaalo, Florence Aber +13 more

Editorial: Recent advancements in mycobacterial diseases research

Frontiers in Microbiology(2024)10.3389/fmicb.2024.1504449

N/A

0DataRank · unranked

2 citations

Jotam G. Pasipanodya, Selvakumar Subbian, Vishwanath Venketaraman, Matt D. Johansen

Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol

medRxiv(2024)10.1101/2024.06.01.24308310

N/A

0DataRank · unranked

0 citations

Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo +12 more